Nottingham University Hospitals

Nottingham, Nottinghamshire NG5 1PB

0 studies enrolling now · 2 studies all time

What they study most

Adult, HER2-Positive Primary Breast Cancer, Hematologic Malignancies, Residual Invasive Breast Cancer

Studies at this site

• A Study of Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in High-risk HER2-positive Participants With Residual Invasive Breast Cancer Following Neoadjuvant Therapy (DESTINY-Breast05) — Running, not enrolling
• A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants With Advanced Hematologic Malignancies — Running, not enrolling